The vaccine book /

Saved in:
Bibliographic Details
Edition:Second edition.
Imprint:London : Academic Press is an imprint of Elsevier, [2016]
©2016
Description:1 online resource (xxvii, 596 pages) : illustrations (some color)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11264888
Hidden Bibliographic Details
Other uniform titles:Preceded by: Vaccine book. ©2003.
Other authors / contributors:Bloom, Barry R., 1937- editor.
Lambert, P. H. (Paul Henri), editor.
ISBN:9780128054000
012805400X
9780128021743
0128021748
Notes:Revised edition of: The vaccine book / edited by Barry R. Bloom, Paul-Henri Lambert. ©2003.
Includes bibliographical references.
Online resource; title from PDF title page (ScienceDirect, viewed July 20, 2016).
Summary:"The Vaccine Book, Second Edition provides comprehensive information on the current and future state of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use. Although vaccines are now available for many diseases, there are still challenges ahead for major diseases, such as AIDS, tuberculosis, and malaria. This book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines. It answers common questions regarding the use of vaccines in the context of a rapidly expanding anti-vaccine environment. This new edition is completely updated and revised with new and unique topics, including new vaccines, problems of declining immunization rates, trust in vaccines, the vaccine hesitancy, and the social value of vaccines for the community vs. the individual child's risk"--Publisher's description.
Other form:Print version: Vaccine book. Second edition. Amsterdam ; Boston : Elsevier/Academic Press, [2016] 9780128021743
Table of Contents:
  • The impact of vaccination on the epidemiology of infectious diseases
  • How vaccines work
  • Vaccine design in the 21st Century
  • Vaccine adjuvants
  • Vaccine production: main steps and considerations
  • How are vaccines assessed in clinical trials?
  • Immunological correlates of vaccine-mediated protection
  • How vaccine safety is monitored
  • Vaccination and autoimmune diseases
  • Maternal immunization: protecting vulnerable populations
  • New challenges for pertussis vaccines
  • Pneumococcus, pneumococcal disease, and prevention
  • Human papillomavirus vaccines
  • Rotavirus vaccines
  • Antiviral vaccines: challenges and advances
  • New approaches for needed vaccines: bacteria
  • Vaccines against parasites
  • Tuberculosis vaccines
  • Major global vaccine challenges: recent progress in malaria vaccine development
  • Aids vaccines
  • Influenza vaccines and vaccination strategies
  • Ethical considerations in vaccine trials in resource-limited settings
  • Economic considerations for the development of global vaccines: a perspective from the vaccine industry
  • Introduction of vaccines into national programs
  • Transitioning immunization into the health care system: strengthening routine immunization in India
  • Vaccine acceptance : barriers, perceived risks, benefits, and irrational beliefs
  • Trust and confidence in vaccines: tales of three vaccines, lessons for others
  • Vaccines for emerging viral diseases
  • Cancer immunotherapy by checkpoint blockade
  • Adoptive cellular therapy with synthetic T cells as an "instant vaccine" for cancer and immunity.